Patent ID: 7605179
Filing Date: 2009-10-20
Classification: A61K,A61P

Abstract:
1. A method of treatment of a neurodegenerative disease or clinical dementia, either being associated with tau protein aggregation, which method comprises administering to a subject a therapeutically effective amount of a compound, wherein the compound is selected from a compound of formula II: wherein R R R M denotes a cation or cations of charge or cumulative charge to counter the charge on the —SO or a compound of formula III: or a compound of formula IV: wherein for formula III or IV: either or R R R R M denotes a cation or cations of charge or cumulative charge to counter the charge on the —SO and a pharmaceutically acceptable salt thereof, or a therapeutic composition comprising the same, such as to inhibit the aggregation of the protein associated with said disease or dementia.